Key Insights

Highlights

Treatment Research

1 treatments under study, led by Standard Of Care Investigator Choice

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting2

Clinical Trials (2)

Research Network

Common Treatments

  • Standard Of Care Investigator Choice1

Active Sponsors

  • Hereditary Neuropathy Foundation1
  • Ambulanzpartner Soziotechnologie APST GmbH1
  • Charite University, Berlin, Germany1

Top Investigators

Related Conditions

  • Charcotmarietooth Disease Type 2b21
  • Charcotmarietooth Disease Type 2g1
  • Charcotmarietooth Disease Type 2m1
  • Neurodegenerative Diseases1
  • Charcotmarietooth Disease Type 2j1

Activity Timeline